Aditxt, Inc. Notes Payable
Aditxt, Inc. (ADTX) had Notes Payable of $44.40 thousand as of 2025-06-07, per its 10-Q filed 2025-11-18.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes and Loans Payable › Notes Payable
us-gaap:NotesPayable · last filed 2025-11-18
- 2025-06-07: Notes Payable $44.40K.
- 2024-12-31: Notes Payable $200.28K.
- 2024-09-30: Notes Payable $0.00.
- 2024-09-08: Notes Payable $5.34K.
| Period end | Notes Payable | Notes Payable as first filed |
|---|---|---|
| 2025-06-07 | $44.40K 10-Q · filed 2025-11-18 | |
| 2024-12-31 | $200.28K 10-K · filed 2025-03-31 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-18 | |
| 2024-09-08 | $5.34K 10-Q · filed 2025-05-15 | |
| 2024-07-12 | $109.56K 10-Q · filed 2024-11-18 | |
| 2024-06-30 | $514.75K 10-Q · filed 2024-08-19 | |
| 2024-01-24 | $44.40K 10-Q · filed 2025-08-14 | $54.87K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |